ArticleInflammatory intestinal diseases2023

Effectiveness and Safety of Golimumab in the Treatment of Ulcerative Colitis: 52-Week Results from Post-Marketing Surveillance in Japan.

Shiro Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.